The aim of the research described was to study Rb2HPW12O40 as a green and heterogeneous catalyst for the Mannich reaction. One-pot multi-component condensation of an aldehyde, an amine and a ketone at ambient temperature affords the corresponding β-amino ketones using novel nano-sized Rb2HPW12O40. Simple purification, short reaction time and high yield are some of the advantages of this reaction. Also, the catalyst can be readily isolated. The nano catalyst Rb2HPW12O40 has been characterized by Fourier transform infrared spectroscopy, X-ray powder diffraction and scanning electron microscopy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17344/acsi.2016.2634 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanistic Understanding of Differences in Cytotoxicity Induced by Food Additives Methyleugenol and Methylisoeugenol.
J Agric Food Chem
January 2025
Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P. R. China.
Methyleugenol (ME) has been classified as a "group 2B carcinogen" by IARC. Its positional isomer methylisoeugenol (MIE) has been considered to be of "generally recognized as safe'' status by FDA. ME was more cytotoxic than MIE in cultured mouse primary hepatocytes.
View Article and Find Full Text PDFNon-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis.
Redox Rep
December 2025
Laboratory of Radiation Biology, Department of Applied Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Targeting ferroptosis, cell death caused by the iron-dependent accumulation of lipid peroxides, and disruption of the redox balance are promising strategies in cancer therapy owing to the physiological characteristics of cancer cells. However, the detection of ferroptosis using imaging remains challenging. We previously reported that redox maps showing the reduction power per unit time of implanted tumor tissues via non-invasive redox imaging using a novel, compact, and portable electron paramagnetic resonance imaging (EPRI) device could be compared with tumor tissue sections.
View Article and Find Full Text PDFBiomechanical comparison of the efficacy of Cfr-PEEK and titanium systems in the fixation following sagittal split advancement osteotomy: a biomechanical study.
BMC Oral Health
January 2025
Department of Oral and Maxillofacial Surgery, Ordu University, Cumhuriyet Yerleşkesi Cumhuriyet Mahallesi, 52200, Ordu, Türkiye, Turkey.
Background: This study evaluates the efficacy of carbon fiber reinforced Polyetheretherketone (Cfr-PEEK) in fixation after sagittal split ramus osteotomy (SSRO) by comparing it with titanium in vitro.
Methods: Twenty-eight sheep hemimandibles were randomly assigned to four groups for SSRO surgery. Fixation was performed with a 4-hole titanium mini plate for 5 mm advancement in Group 1, with a 4-hole Cfr-PEEK mini plate for 5 mm advancement for Group 2, with a 4-hole titanium mini plate for 10 mm advancement for Group 3, and with a 4-hole Cfr-PEEK mini plate for 10 mm advancement for Group 4.
Differential effects of β-hydroxybutyrate and α-ketoglutarate on HCT-116 colorectal cancer cell viability under normoxic and hypoxic low-glucose conditions: exploring the role of SRC, HIF1α, ACAT1, and SIRT2 genes.
Mol Genet Genomics
January 2025
Autophagy Research Center, Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Recent therapeutic strategies have highlighted the potential of β-hydroxybutyrate (BHB) and α-ketoglutarate (α-KG) as effective anticancer agents, particularly for colon cancer. These metabolites can modulate cellular metabolism and induce epigenetic changes, inhibiting tumor growth. Nonetheless, certain cancer cells may utilize ketone bodies, like BHB as nutrient sources under hypoxic conditions, potentially reducing treatment efficacy.
View Article and Find Full Text PDFTargeting estrogen-regulated system x promotes ferroptosis and endocrine sensitivity of ER+ breast cancer.
Cell Death Dis
January 2025
Wenzhou Key Laboratory of Cancer Pathogenesis and Translation, Key Laboratory of Laboratory Medicine, School of Laboratory Medicine and Life Sciences, Ministry of Education, Wenzhou Medical University, 325035, Wenzhou, China.
Estrogen receptor positive (ER+) breast cancer accounts for approximately 70% of cases. Endocrine therapies targeting estrogen are the first line therapies for ER+ breast cancer. However, resistance to these therapies occurs in about half of patients, leading to decreased survival rates.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!